During the past decade, Capstone Clinical Research conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 35 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 21 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capstone Clinical Research" #1 sponsor was "Shire" with 16 trials, followed by "Sunovion" with 9 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 6 trials sponsored, "Forest Laboratories" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capstone Clinical Research" #1 collaborator was "Noven Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Capstone Clinical Research" are "Major Depressive Disorder" (13 trials), "Binge Eating Disorder" (7 trials), "Depressive Disorder, Major" (7 trials), "ADHD" (4 trials) and "Attention Deficit Hyperactivity Disorder" (4 trials). Many other conditions were trialed in "Capstone Clinical Research" in a lesser frequency.

Most popular intervention types in "Capstone Clinical Research" are "Drug" (61 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Rapastinel" (6 trials), "Dasotraline" (5 trials), "Lisdexamfetamine dimesylate" (4 trials) and "SPD489 (Lisdexamfetamine dimesylate)" (3 trials). Other intervention names were less common.

The vast majority of trials in "Capstone Clinical Research" are 61 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Capstone Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in Capstone Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Capstone Clinical Research, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 1 trials that are defined as “Not Applicable".